Your browser doesn't support javascript.
loading
Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy.
Wang, Zongwei; Deng, Tuo; Long, Xingbo; Lin, Xueming; Wu, Shulin; Wang, Hongbo; Ge, Rongbin; Zhang, Zhenwei; Wu, Chin-Lee; Taplin, Mary-Ellen; Olumi, Aria F.
Afiliação
  • Wang Z; Department of Surgery, Division of Urology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
  • Deng T; Department of Pathology and Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America.
  • Long X; Department of Surgery, Division of Urology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
  • Lin X; Department of Urology, Minimally Invasive Surgery center, The First Affiliated Hospital of Guangzhou Medical University, Guangdong Key Laboratory of Urology, Guangzhou Institute of Urology, Guangzhou, Guangdong, China.
  • Wu S; Department of Urology, Union Medical College, Beijing, China.
  • Wang H; Department of Pathology and Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America.
  • Ge R; Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Zhang Z; Department of Pathology and Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America.
  • Wu CL; Department of Pathology and Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America.
  • Taplin ME; Department of Pathology, University of Massachusetts Medical School, Worcester, MA, United States of America.
  • Olumi AF; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States of America.
PLoS One ; 15(3): e0229754, 2020.
Article em En | MEDLINE | ID: mdl-32134978
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: 3-Oxo-5-alfa-Esteroide 4-Desidrogenase / Inibidores de 5-alfa Redutase / Neoplasias de Próstata Resistentes à Castração / Dutasterida / Androstenos / Proteínas de Membrana Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: 3-Oxo-5-alfa-Esteroide 4-Desidrogenase / Inibidores de 5-alfa Redutase / Neoplasias de Próstata Resistentes à Castração / Dutasterida / Androstenos / Proteínas de Membrana Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article